3.2
Impact Factor
 
 ◂ Last issue Next issue ▸ Archive Cover PDF
Volume 10 (25); 2019
Research Papers
Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial 
 Seung Tae  Kim, Sung Yong  Oh, Jeeyun  Lee, Jung Hun  Kang, Hyun Woo  Lee, Myung Ah  Lee, Byeong Seok  Sohn, Ji Hyong  Hong, Young Suk  Park, Joon Oh  Park, Ho Yeong  Lim 
 
J. Cancer 2019;  10(25): 6185-6190. doi:10.7150/jca.37610 
Full text
PDF PubMed
 PMC
The clinicopathological characteristic associations of long non-coding RNA gene H19 polymorphisms with uterine cervical cancer 
 Ming-Chao  Huang, Ying-Hsiang  Chou, Huang-Pin  Shen, Soo-Cheen  Ng, Yueh‐Chun  Lee, Yi-Hung  Sun, Chun-Fang  Hsu, Shun-Fa  Yang, Po-Hui  Wang 
 
J. Cancer 2019;  10(25): 6191-6198. doi:10.7150/jca.36707 
Full text
PDF PubMed
 PMC
Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma 
 Li-Xin  Liu, Jia-Cheng  Lu, Hai-Ying  Zeng, Jia-Bin  Cai, Peng-Fei  Zhang, Xiao-Jun  Guo, Xiao-Yong  Huang, Rui-Zhao  Dong, Chi  Zhang, Qiang  Kang, Hao  Zou, Xin-Yu  Zhang, Lu  Zhang, Xiao-Wen  Zhang, Ai-Wu  Ke, Guo-Ming  Shi 
 
J. Cancer 2019;  10(25): 6199-6206. doi:10.7150/jca.36301 
Full text
PDF PubMed
 PMC
p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer 
 Liuxi  Chen, Ying  Liu, Qi  Zhang, Mingming  Zhang, Xuemeng  Han, Qiujie  Li, Tian  Xie, Qibiao  Wu, Xinbing  Sui 
 
J. Cancer 2019;  10(25): 6207-6216. doi:10.7150/jca.37335 
Full text
PDF PubMed
 PMC
The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial 
 Petros  Alexidis, Dimitris  Dragoumis, Sotirios  Karatzoglou, Konstantinos  Drevelegas, Ioannis  Tzitzikas, Konstantinos  Hatzimouratidis, Ioannis  Chrisogonidis, Dimitris  Giannakidis, Charilaos  Koulouris, Athanasios  Katsaounis, Nikolaos  Michalopoulos, Haidong  Huang, Qiang  Li, Zoi  Aidoini, Varbara  Fyntanidou, Aikaterini  Amaniti, Wolfgang  Hohenforst-Schmidt, Elena  Maragouli, Savvas  Petanidis, Paul  Zarogoulidis, Konstantinos  Sapalidis, Christoforos  Kosmidis, Konstantinos  Romanidis, Panagoula  Oinkonomou, Anastasios  Vagionas, Iason  Nikolaos-Katsios, Aris  Ioannidis, Konstantina  Boniou, Isaak  Kesisoglou 
 
J. Cancer 2019;  10(25): 6217-6224. doi:10.7150/jca.35510 
Full text
PDF PubMed
 PMC
Effects of Postoperative Radiotherapy in Early Breast Cancer Patients Older than 75 Years: A Propensity-Matched Analysis 
 Linghui  Zhou, Pengtao  Yang, Yi  Zheng, Tian  Tian, Cong  Dai, Meng  Wang, Shuai  Lin, Yujiao  Deng, Qian  Hao, Zhen  Zhai, Hongtao  Li, Zhijun  Dai 
 
J. Cancer 2019;  10(25): 6225-6232. doi:10.7150/jca.35204 
Full text
PDF PubMed
 PMC
Efficacy and Safety of Intro-Arterial Chemotherapy Combined with Radiotherapy on Head and Neck Cancer: A Systematic Review and Meta-Analysis 
 Yan  Huang, Li-Ling  Wu, Ruo-Lan  Xiang, Guang-Yan  Yu 
 
J. Cancer 2019;  10(25): 6233-6243. doi:10.7150/jca.36478 
Full text
PDF PubMed
 PMC
Cumulative Score Based on Preoperative Fibrinogen and Pre-albumin Could Predict Long-term Survival for Patients with Resectable Gastric Cancer 
 Zhi-jun  Wu, Hui  Xu, Rong  Wang, Li-jia  Bu, Jie  Ning, Ji-qing  Hao, Guo-ping  Sun, Tai  Ma 
 
J. Cancer 2019;  10(25): 6244-6251. doi:10.7150/jca.35157 
Full text
PDF PubMed
 PMC
High expression of PDE4D correlates with poor prognosis and clinical progression in pancreaticductal adenocarcinoma 
 Fude  Liu, Jieyi  Ma, Kebing  Wang, Zhi  Li, Qingping  Jiang, Hui  Chen, Wen  Li, Jintang  Xia 
 
J. Cancer 2019;  10(25): 6252-6260. doi:10.7150/jca.35443 
Full text
PDF PubMed
 PMC
GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-κB/VEGF pathway 
 Yong Hyun  Park, Ae Ryang  Jung, Ga Eun  Kim, Mee Young  Kim, Jae Woo  Sung, Dongho  Shin, Hyuk Jin  Cho, U-Syn  Ha, Sung-Hoo  Hong, Sae Woong  Kim, Ji Youl  Lee 
 
J. Cancer 2019;  10(25): 6269-6277. doi:10.7150/jca.34859 
Full text
PDF PubMed
 PMC
RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma 
 Wanfu  Men, Wenya  Li, Yu  Li, Jungang  Zhao, Xiaohan  Qu, Peiwen  Li, Shulei  Gong 
 
J. Cancer 2019;  10(25): 6278-6285. doi:10.7150/jca.35072 
Full text
PDF PubMed
 PMC
Galectin-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating EMT Signaling 
 Xiaolan  You, Qinghong  Liu, Jian  Wu, Yuanjie  Wang, Jiawen  Dai, Dehu  Chen, Yan  Zhou, Yanjun  Lian 
 
J. Cancer 2019;  10(25): 6286-6297. doi:10.7150/jca.33765 
Full text
PDF PubMed
 PMC
Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma 
 Shan-Shan  Luo, Xi-Wen  Liao, Xiao-Dong  Zhu 
 
J. Cancer 2019;  10(25): 6298-6313. doi:10.7150/jca.33250 
Full text
PDF PubMed
 PMC
Natural History of Pediatric Low-Grade Glioma Disease - First Multi-State Model Analysis 
 Anna-Maria  Goebel, Astrid K.  Gnekow, Daniela  Kandels, Olaf  Witt, Rene  Schmidt, Pablo Hernáiz  Driever 
 
J. Cancer 2019;  10(25): 6314-6326. doi:10.7150/jca.33463 
Full text
PDF PubMed
 PMC
Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells 
 Ming  Gu, Wenhui  Zheng, Mingdi  Zhang, Xiaoshen  Dong, Yan  Zhao, Shuo  Wang, Haiyang  Jiang, Lu  Liu, Xinyu  Zheng 
 
J. Cancer 2019;  10(25): 6341-6348. doi:10.7150/jca.34910 
Full text
PDF PubMed
 PMC
Impact of tumour size on metastasis and survival in patients with pancreatic neuroendocrine tumours (PNETs): A population based study 
 Yangyang  Liu, Shufang  Ye, Yabi  Zhu, Xingkang  He, Jie  Pan, Shujie  Chen, Bin  Ye, Liangjing  Wang 
 
J. Cancer 2019;  10(25): 6349-6357. doi:10.7150/jca.27779 
Full text
PDF PubMed
 PMC
H19 gene polymorphisms and neuroblastoma susceptibility in Chinese children: a six-center case-control study 
 Yong  Li, Zhen-Jian  Zhuo, Haiyan  Zhou, Jiabin  Liu, Jiao  Zhang, Jiwen  Cheng, Haixia  Zhou, Suhong  Li, Ming  Li, Jun  He, Zhenghui  Xiao, Jing  He, Yaling  Xiao 
 
J. Cancer 2019;  10(25): 6358-6363. doi:10.7150/jca.37564 
Full text
PDF PubMed
 PMC
MTBHsp70-exFPR1-pulsed Dendritic Cells Enhance the Immune Response against Cervical Cancer 
 Guangming  Cao, Ran  Cui, Chongdong  Liu, Guyu  Zhang, Zhenyu  Zhang 
 
J. Cancer 2019;  10(25): 6364-6373. doi:10.7150/jca.29779 
Full text
PDF PubMed
 PMC
CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients 
 Li-Ming  Tan, Xi  Li, Cheng-Feng  Qiu, Tao  Zhu, Cheng-Ping  Hu, Ji-Ye  Yin, Wei  Zhang, Hong-Hao  Zhou, Zhao-Qian  Liu 
 
J. Cancer 2019;  10(25): 6374-6383. doi:10.7150/jca.30139 
Full text
PDF PubMed
 PMC
The screening of pivotal gene expression signatures and biomarkers in renal carcinoma 
 Hailong  Ruan, Sen  Li, Junwei  Tong, Qi  Cao, Zhengshuai  Song, Keshan  Wang, Yu  huang, Lin  Bao, Xuanyu  Chen, Hongmei  Yang, Ke  Chen, Xiaoping  Zhang 
 
J. Cancer 2019;  10(25): 6384-6394. doi:10.7150/jca.30656 
Full text
PDF PubMed
 PMC
Interplay of PKD3 with SREBP1 Promotes Cell Growth via Upregulating Lipogenesis in Prostate Cancer Cells 
 Ling  Li, Liang  Hua, Huihui  Fan, Yu  He, Wanfu  Xu, Lin  Zhang, Jie  Yang, Fan  Deng, Fangyin  Zeng 
 
J. Cancer 2019;  10(25): 6395-6404. doi:10.7150/jca.31254 
Full text
PDF PubMed
 PMC
Up-regulation of LINC00467 promotes the tumourigenesis in colorectal cancer 
 Xiaoyun  He, Shen  Li, Bingbing  Yu, Gaoyan  Kuang, Yongrong  Wu, Meili  Zhang, Yuxiang  He, Chunlin  Ou, Pengfei  Cao 
 
J. Cancer 2019;  10(25): 6405-6413. doi:10.7150/jca.32216 
Full text
PDF PubMed
 PMC
Long Intergenic Noncoding RNA 00261 Acts as a Tumor Suppressor in Non-Small Cell Lung Cancer via Regulating miR-105/FHL1 Axis 
 Zhiqiang  Wang, Jiru  Zhang, Bo  Yang, Runsheng  Li, Linfang  Jin, Zhenjun  Wang, Haifeng  Yu, Chuanxin  Liu, Yong  Mao, Qingjun  You 
 
J. Cancer 2019;  10(25): 6414-6421. doi:10.7150/jca.32251 
Full text
PDF PubMed
 PMC
Double-edged role of radiotherapy in patients with pulmonary large-cell neuroendocrine carcinoma 
 Yuanzhu  Jiang, Cong  Lei, Xufeng  Zhang, Yangang  Cui, Keying  Che, Hongchang  Shen 
 
J. Cancer 2019;  10(25): 6422-6430. doi:10.7150/jca.32446 
Full text
PDF PubMed
 PMC
Liensinine inhibited gastric cancer cell growth through ROS generation and the PI3K/AKT pathway 
 Jia-hua  Yang, Kun  Yu, Xian-ke  Si, Sen  Li, Yi-jun  Cao, Wei  Li, Ji-xun  Zhang 
 
J. Cancer 2019;  10(25): 6431-6438. doi:10.7150/jca.32691 
Full text
PDF PubMed
 PMC
Jiedu Sangen Decoction Reverses Epithelial-to-mesenchymal Transition and Inhibits Invasion and Metastasis of Colon Cancer via AKT/GSK-3β Signaling Pathway 
 Li  Yuan, Kai  Zhang, Meng-Meng  Zhou, Harpreet S.  Wasan, Fang-Fang  Tao, Qing-Ying  Yan, Guan  Feng, Yin-Shan  Tang, Min-He  Shen, Sheng-Lin  Ma, Shan-Ming  Ruan 
 
J. Cancer 2019;  10(25): 6439-6456. doi:10.7150/jca.32873 
Full text
PDF PubMed
 PMC
Association between gene methylation and HBV infection in hepatocellular carcinoma: A meta-analysis 
 Cheng  Zhang, Changxin  Huang, Xinbing  Sui, Xueqing  Zhong, Wenjun  Yang, Xiangrong  Hu, Yongqiang  Li 
 
J. Cancer 2019;  10(25): 6457-6465. doi:10.7150/jca.33005 
Full text
PDF PubMed
 PMC
Establishment and characterization of novel human primary endometrial cancer cell line (ZJB-ENC1) and its genomic characteristic 
 Xiaozhen  Liu, Zhuozhuo  Ren, Yu  Xu, Wei  Sun, Yongfeng  Li, Xinmiao  Rui, Dafei  Xie, Xuli  Meng, Zhiguo  Zheng 
 
J. Cancer 2019;  10(25): 6466-6474. doi:10.7150/jca.33013 
Full text
PDF PubMed
 PMC
Reviews
Immune-Checkpoint Inhibitors as the First Line Treatment of Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials 
 Yuqiao  Chen, Yuan  Zhou, Lu  Tang, Xiong  Peng, Hong  Jiang, Guo  Wang, Wei  Zhuang 
 
J. Cancer 2019;  10(25): 6261-6268. doi:10.7150/jca.34677 
Full text
PDF PubMed
 PMC
Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry 
 Xue  Zhang, Jigang  Zhang, Heming  Zhou, Guorong  Fan, Qin  Li 
 
J. Cancer 2019;  10(25): 6327-6340. doi:10.7150/jca.34171 
Full text
PDF PubMed
 PMC